FDA Drug recall D-0790-2017
Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Can…
- FDA Drug
- Class III
- terminated
- Published 2017-05-24
On 2017-05-24 the FDA classified a Class III recall of Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Can… by Taro Pharmaceuticals U, citing cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0790-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-03-17 |
| Published | 2017-05-24 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Taro Pharmaceuticals U |
| Distribution | US |
Product
Fluocinonide Cream UPS, 0.05% (Emulsified Base), packaged in 60 g tube, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada, Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1254-3
Reason
Cross contamination with other products: Certain lots of Fluocinonide Cream were found to be contaminated with a small quantity of hydrocortisone-17-valerate.
Identifiers
| ndc | 51672-1253-1 |
|---|---|
| ndc | 51672-1253-2 |
| ndc | 51672-1253-3 |
| ndc | 51672-1253-4 |
| ndc | 51672-1254-1 |
| ndc | 51672-1254-2 |
| ndc | 51672-1254-3 |
| ndc | 51672-1279-1 |
| ndc | 51672-1279-2 |
| ndc | 51672-1279-3 |
| ndc | 51672-1264-1 |
| ndc | 51672-1264-2 |
| ndc | 51672-1264-3 |
| code_info | Lot #: D301311473, D301411473, Exp 3/2017 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0790-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.